Published in Antimicrob Agents Chemother on October 07, 2013
Are we there yet? The smallpox research agenda using variola virus. PLoS Pathog (2014) 0.77
Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease. PLoS One (2015) 0.75
Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrob Agents Chemother (2015) 0.75
Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A (2002) 7.78
The looming threat of bioterrorism. Science (1999) 5.58
Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol (1980) 4.24
The formation and function of extracellular enveloped vaccinia virus. J Gen Virol (2002) 4.14
Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J Virol (1991) 3.79
Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis (2001) 3.39
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J Virol (2005) 3.36
Diagnosis and management of smallpox. N Engl J Med (2002) 3.20
Smallpox: the triumph over the most terrible of the ministers of death. Ann Intern Med (1997) 2.69
Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol (1993) 2.64
Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis (2003) 2.46
Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci U S A (2004) 2.36
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis (2008) 2.00
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother (2006) 1.92
Ring vaccination and smallpox control. Emerg Infect Dis (2004) 1.88
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Am J Trop Med Hyg (2007) 1.86
Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother (2009) 1.52
Preventing second-generation infections in a smallpox bioterror attack. Epidemiology (2004) 1.51
Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. Antiviral Res (2008) 1.50
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother (2009) 1.45
ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation. Antimicrob Agents Chemother (2009) 1.07
Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis. Virol J (2009) 1.03
Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice. Proc Natl Acad Sci U S A (2009) 1.03
Modelling responses to a smallpox epidemic taking into account uncertainty. Epidemiol Infect (2004) 0.95
Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis (2012) 0.93
Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects. Antimicrob Agents Chemother (2010) 0.91
Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R. Antiviral Res (2005) 0.88
Progression of pathogenic events in cynomolgus macaques infected with variola virus. PLoS One (2011) 0.87
Smallpox as an etiologic factor in male infertility. Fertil Steril (1973) 0.85
Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers. Antimicrob Agents Chemother (2012) 0.81
Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers. Antimicrob Agents Chemother (2012) 0.79
The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med (2004) 6.32
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature (2004) 3.65
The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives. Am J Public Health (2008) 3.09
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48
Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis (2004) 2.45
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology (2005) 2.36
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis (2008) 2.27
A tale of two clades: monkeypox viruses. J Gen Virol (2005) 2.24
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. Clin Cancer Res (2006) 2.20
Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics (2007) 2.10
Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J (2005) 2.07
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood (2007) 2.01
Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg (2010) 1.99
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother (2006) 1.92
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis (2002) 1.92
Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg (2005) 1.91
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection. Am J Trop Med Hyg (2007) 1.86
Clinical safety of a viral vector based prostate cancer vaccine strategy. J Urol (2007) 1.84
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
On the origin of smallpox: correlating variola phylogenics with historical smallpox records. Proc Natl Acad Sci U S A (2007) 1.84
Detection of monkeypox virus with real-time PCR assays. J Clin Virol (2006) 1.77
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis (2006) 1.71
Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins. Virol J (2006) 1.69
Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg (2005) 1.69
Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68
Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak. Am J Trop Med Hyg (2007) 1.67
Brazilian vaccinia viruses and their origins. Emerg Infect Dis (2007) 1.64
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol (2005) 1.62
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
The vaccinia virus I7L gene product is the core protein proteinase. J Virol (2002) 1.61
Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer. J Urol (2005) 1.59
Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis (2005) 1.54
Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo. Am J Trop Med Hyg (2009) 1.54
Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother (2009) 1.52
Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. Antiviral Res (2008) 1.50
Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J Clin Invest (2005) 1.50
A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus. J Gen Virol (2009) 1.49
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology (2014) 1.47
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother (2009) 1.45
Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res (2003) 1.44
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Ecological niche and geographic distribution of human monkeypox in Africa. PLoS One (2007) 1.41
National surveillance for human and pet contact with oral rabies vaccine baits, 2001-2009. J Am Vet Med Assoc (2012) 1.39
Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Res (2005) 1.38
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother (2007) 1.38
Costimulatory molecules as adjuvants for immunotherapy. Front Biosci (2006) 1.37
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Chasing Jenner's vaccine: revisiting cowpox virus classification. PLoS One (2011) 1.33
Real-time PCR assay to detect smallpox virus. J Clin Microbiol (2003) 1.32
Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis (2006) 1.30
Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis (2004) 1.26
Kawasaki syndrome in Denmark. Pediatr Infect Dis J (2007) 1.24
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor. Antimicrob Agents Chemother (2008) 1.24
Identification of a broad-spectrum arenavirus entry inhibitor. J Virol (2008) 1.23
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. J Virol (2008) 1.22
Evaluation of smallpox vaccines using variola neutralization. J Gen Virol (2009) 1.21
Molecular dissection of the vaccinia virus I7L core protein proteinase. J Virol (2003) 1.20
Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol (2007) 1.20
In vitro efficacy of ST246 against smallpox and monkeypox. Antimicrob Agents Chemother (2008) 1.19
Infection control practices and zoonotic disease risks among veterinarians in the United States. J Am Vet Med Assoc (2008) 1.18
Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures. Antivir Ther (2007) 1.17
Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol (2012) 1.17
Escherichia coli DegP protease cleaves between paired hydrophobic residues in a natural substrate: the PapA pilin. J Bacteriol (2002) 1.16
GC content-based pan-pox universal PCR assays for poxvirus detection. J Clin Microbiol (2009) 1.15
Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J (2003) 1.15
Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med (2005) 1.15
Viral meningitis-associated hospitalizations in the United States, 1988-1999. Neuroepidemiology (2003) 1.13
A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease. Am J Trop Med Hyg (2010) 1.13
Discovery of monkeypox in Sudan. N Engl J Med (2006) 1.13
Vaccines with enhanced costimulation maintain high avidity memory CTL. J Immunol (2005) 1.12
Lymphocyte death in a mouse model of Ebola virus infection. J Infect Dis (2007) 1.12
National surveillance and the epidemiology of human Q fever in the United States, 1978-2004. Am J Trop Med Hyg (2006) 1.12
Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr (2012) 1.12
The phylogenetics and ecology of the orthopoxviruses endemic to North America. PLoS One (2009) 1.12
Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease. Virology (2010) 1.12